Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 40 EP applications Stephen Garner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12748087

PURIFIED PROTEINS

IPC classification:
A61K 38/20, C07K 14/545, B01D 15/36
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14164650

Genz 112638 for treating Gaucher or Fabry disease in combination therapy

IPC classification:
A61K 31/4025, C07D 405/06, A61P 35/00
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13804115

COMPOSITIONS AND METHODS FOR TRANSMUCOSAL ABSORPTION

IPC classification:
A61K 31/135, A61K 9/00
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13765893

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:
A61K 31/439, C07D 471/08, C07D 453/02, A61P 35/00, A61P 25/00
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13853407

BIOGLASS WITH GLYCOSAMINOGLYCANS

IPC classification:
A61K 33/04, A61K 9/14, A61F 13/00
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13789690

COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES

IPC classification:
A61K 38/46, A61P 25/28
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13811641

IL-6 ANTAGONISTS AND USES THEREOF

IPC classification:
C07K 16/24, A61P 27/02
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13863954

BIOACTIVE GLASS WITH ETHYLENE OXIDE PROPYLENE OXIDE BLOCK COPOLYMERS

IPC classification:
A61F 2/28
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15176068

SOLID COMPOSITIONS

IPC classification:
A61K 31/00, A61K 9/20, A61K 9/16, A61K 9/14
Applicant:
AbbVie Bahamas Limited
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP14718854

SALT FORMS OF (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE

IPC classification:
A61P 3/00, A61P 35/00, A61K 31/439, C07D 453/00
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14723554

PIPERAZINE DERIVATIVES AND THEIR USE AS KIT MODULATORS

IPC classification:
A61P 17/00, A61K 31/5377, A61K 31/517, C07D 487/04, C07D 239/94, C07D 409/14, C07D 403/14, C07D 403/04, C07D 401/12, C07D 413/14, C07D 405/14
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14768673

SODIUM CONTAINING SOL-GEL DERIVED BIOACTIVE GLASSES AND USES THEREOF INCLUDING HEMOSTASIS

IPC classification:
C08K 9/06, C03C 3/078
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14722435

CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY

IPC classification:
A61K 47/26, A61K 47/10, A61K 9/00, A61K 38/20
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14772580

COMPOSITIONS AND METHODS FOR MANUFACTURING SOL-GEL DERIVED BIOACTIVE BOROPHOSPHATE GLASSES FOR MEDICAL APPLICATONS

IPC classification:
C08K 9/06, C03C 3/078
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14718835

METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:
C07D 277/30, C07D 417/06, C07D 453/02
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14733757

ALBUMIN VARIANTS BINDING TO FCRN

IPC classification:
G01N 33/50
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Rachel Clare Williams, Novozymes Biopharma UK Limited
Status:
EXAMINATION IN PROGRESS
EP15187794

PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
A61K 31/50
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
The patent has been granted
EP14799576

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

IPC classification:
A61K 31/53, A61P 35/00, C07D 487/04
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14802532

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

IPC classification:
A61P 35/00, A61K 31/498, C07D 409/12, C07D 403/14, C07D 405/12, C07D 235/30, C07D 401/12, C07D 401/04, C07D 403/12
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14805204

SOLID PHARMACEUTICAL COMPOSITIONS USEFUL IN HCV TREATMENT

IPC classification:
A61P 31/22, A61K 31/497, A61K 31/4025, A61K 31/427, A61K 9/20, A61K 9/14, A61K 47/32, A61K 47/22, A61K 47/14, A61K 9/00
Applicant:
AbbVie Deutschland GmbH & Co KG
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP14824245

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:
A61P 9/00, A61K 31/439
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15701431

SOLID ANTIVIRAL DOSAGE FORMS

IPC classification:
A61P 31/14, A61K 31/513, A61K 31/497, A61K 31/427, A61K 31/4025, A61K 9/24, A61K 47/38, A61K 47/32
Applicant:
AbbVie Deutschland GmbH & Co KG
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP15714117

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

IPC classification:
C07K 16/40, C07K 16/32, C07K 16/28, A61K 47/60
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15727109

CRYSTAL FORMS

IPC classification:
A61P 31/14, A61K 38/05, A61K 31/4178, C07D 519/00, C07D 417/14, C07D 413/14, C07D 405/14, C07D 403/14, C07D 401/10, C07D 207/16
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP16175117

ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT

IPC classification:
A61P 35/00, A61K 31/4025, A61K 45/06, C07D 405/06
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15727798

NAMPT INHIBITORS AND METHODS

IPC classification:
A61P 37/06, A61P 35/00, A61P 31/12, A61K 31/537, A61K 31/444, A61K 31/438, C07D 498/10, C07D 491/20, C07D 491/107
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15803592

CRYSTAL FORMS

IPC classification:
A61K 38/12
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP15841528

EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE

IPC classification:
A61P 21/02, A61K 31/047, A61K 31/135
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP15847215

METHODS OF TREATING MUCOPOLYSACCHARIDOSIS IIIB (MPSIIIB)

IPC classification:
C12N 9/24, A61K 38/47
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP17158770

LYSOSOMAL STORAGE DISEASE ENZYME

IPC classification:
A61K 38/38, C12N 9/20, A61K 31/194, A01K 67/027, A61P 3/06, A61K 31/135, A61K 31/397, A61K 31/366, A61K 38/46
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
The application has been published
EP15791424

CARBIDOPA AND L-DOPA PRODRUGS AND THEIR USE TO TREAT PARKINSON'S DISEASE

IPC classification:
A61P 25/16, A61K 31/6615, A61K 31/661
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16706041

LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE

IPC classification:
A61K 31/198, A61K 31/195, A61K 47/38, A61K 9/10, A61K 9/00
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16711088

METHODS FOR TREATING PROTEINOPATHIES

IPC classification:
A61P 25/28, A61P 25/16, A61K 31/439, A61K 31/00
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16812577

BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
A61P 25/00, A61K 31/5513, C07D 487/14
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16738291

SOLID PHARMACEUTICAL COMPOSITIONS FOR TREATING HCV

IPC classification:
A61P 31/14, A61K 31/498, A61K 31/454, A61K 9/24, A61K 9/20, A61K 9/14
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16745350

COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO KIT AND PDGFR

IPC classification:
A61P 35/00, A61K 31/53, C07D 487/04
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16745584

SOLID PHARMACEUTICAL COMPOSITIONS FOR TREATING HCV

IPC classification:
A61P 31/14, A61K 31/498, A61K 31/454, A61K 9/24, A61K 9/20, A61K 9/14
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16763630

COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16766172

ANTI-VIRAL TETRAHYDROFURANE DERIVATIVES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/06
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP17210362

SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING AN HIV PROTEASE INHIBITOR SOLID DISPERSION

IPC classification:
A61K 31/425, A61K 9/20, A61K 9/14
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
The application has been published

Please Sign in to use this feature